Authors
Junjie Liu, Huiquan Zuo, Guoyu Zhang, Qing Wang, Xing Guo, Heng Li, Shaozhen Wang, Lijuan Jiao, Erhong Hao
Published in
Chemical communications (Cambridge, England). Nov 09, 2026. Epub Nov 09, 2026.
Abstract
Phototherapeutic agents that simultaneously integrate near-infrared absorption, combined photothermal/photodynamic therapy, and organelle targeting remain rare. Herein, β-α-α-β-triBODIPYs (BDP1-5) were designed by linking two BODIPY units at the α-positions of a central core. This architecture extended π-conjugation and split the absorption band, with a maximum at ∼780 nm, enabling high photothermal conversion (77.7%) and type I ROS generation. BDP5 NPs achieve lysosomal targeting, realize efficient tumor reduction in vivo, demonstrating integrated PTT/PDT potential.
PMID:
43002174
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0